Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
Clinical trial NCT01529034 · TERMINATED
Trial details
- NCT number
- NCT01529034
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2017-04-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.